Document:

Form Stock Option Grant Agreement

 Exhibit 10.8.2 
 STOCK OPTION GRANT AGREEMENT 
 (Non-Qualified Stock
Options) 
 THIS AGREEMENT is made as of this
                day of                 , 2009 by and between LVB Acquisition, Inc. (the
“Company”) and NAME (the “Participant”). 
 WHEREAS, the Company has adopted and maintains the
LVB Acquisition, Inc. Management Equity Incentive Plan (the “Plan”) to promote the interests of the Company and its Affiliates and stockholders by providing the Company’s key employees and others with an appropriate incentive
to encourage them to continue in the employ of and provide services for the Company or its Affiliates and to improve the growth and profitability of the Company; and 
 WHEREAS, the Plan provides for the Grant to Participants in the Plan of Non-Qualified Stock Options to purchase shares of Common Stock of the Company; 

NOW, THEREFORE, in consideration of the premises and mutual covenants set forth herein, the parties hereto hereby agree as follows:

 1. Grant of Options. Pursuant to, and subject to, the terms and conditions set forth herein and in the Plan, the
Company hereby grants to the Participant a NON-QUALIFIED STOCK OPTION (the “Option”) with respect to [                ] shares of Common Stock of the
Company. Seventy-five percent (75%) of the Option (representing an Option to purchase [                ] shares) will be a time based Option (the “Time
Based Option”) and twenty-five percent (25%) of the Option (representing an Option to purchase [                ] shares) will be a performance based
Option (the “Performance Vesting Option”), in each case pursuant to the terms and conditions set forth in this Agreement. 
 2. Grant Date. The Grant Date of the Option hereby granted is [            ]. 

3. Incorporation of Plan. Unless stated otherwise, all terms, conditions and restrictions of the Plan are incorporated herein and
made part hereof as if stated herein. All capitalized terms used and not defined herein shall have the meaning given to such terms in the Plan. 
 4. Exercise Price. The exercise price per share of Common Stock underlying the Option hereby granted is $10.00. 
 5. Vesting Date. The Option shall become exercisable as follows: 
 a. With respect to the portion of the Option that is a Time Based Option, twenty percent (20%) of such Time Based Option shall vest on
[            ] in each of calendar years [            ],
[            ], [            ], [            ] and
[            ]; 

 b. With respect to the portion of the Option that is a Performance Vesting
Option, twenty percent (20%) of such Performance Vesting Option shall vest on [            ] in each of calendar years
[            ], [            ], [            ],
[            ] and [            ] if, as of the end of the Company’s most recent fiscal year ending on or prior to such
Vesting Date, Biomet, Inc. has achieved the EBITDA target set forth below for such fiscal year: 
  

													
	 Fiscal
Year                                         
   
	  	2010	  	2011	  	2012	  	2013	  	[2014]	  	[2015]
	 EBITDA Target (in millions)
	  		  		  		  		  		  	

 subject in each case to the Participant’s continued Employment through each such Vesting Date. 

If any portion of the Performance Vesting Option does not vest on the Vesting Date on which it initially becomes eligible to vest in accordance with the
preceding sentence because Biomet, Inc. did not meet the EBITDA target set forth above for the relevant fiscal year (any such year, the “Below-Target Year”), then such portion (the “Catch-Up Tranche”) shall remain
outstanding and shall be eligible to vest as follows: 
 (i) If Biomet, Inc. exceeds the EBITDA target set forth above for the
fiscal year immediately following such Below-Target Year (the “Catch-Up Year”) by an amount large enough so that (I) the sum of Biomet, Inc.’s actual EBITDA in the Below-Target Year and its actual EBITDA in the Catch-Up
Year exceeds (II) the sum of the EBITDA target set forth above for the Below-Target Year and the EBITDA target set forth above for the Catch-Up Year, then such Catch-Up Tranche will vest as of the Vesting Date that occurs on or next following the
last day of the Catch-Up Year. 
 (ii) If either: 

(A) After the end of the Below-Target Year, a Liquidity Event occurs in which the Majority Stockholder realizes an MoM
that is at least 2.0; or 
 (B) (1) An Initial Public Offering has occurred, (2) the Majority Stockholder
has sold, directly or indirectly, in one or more Liquidity Event(s), 80% or more of the Initial Majority Stockholder Shares (determined based on the number of the Initial Majority Stockholder Shares as of the Closing date) and (3) the Majority
Stockholder has realized, directly or indirectly, in such Liquidity Event(s) an MoM that is at least 2.0 (provided that MoM for this purpose shall be determined by multiplying clause (ii) of Section 2(dd) of the Plan by a fraction,
the numerator of which is the number of Initial Majority Stockholder Shares disposed of in all such Liquidity Events and the denominator of which is the number of the Initial Majority Stockholder Shares as of the Closing date); 

  
 2 

 then any Catch-Up Tranche that remains unvested as of the occurrence of the Liquidity Event
(or, in the case of clause B above, the later of the occurrence of the Liquidity Event or the fifth anniversary of the Closing) shall immediately vest upon the occurrence of the Liquidity Event (or, in the case of clause B above, the later of the
occurrence of the Liquidity Event or the fifth anniversary of the Closing), provided the Participant remains Employed through such Vesting Date. 
 6. Expiration Date. Subject to the provisions of the Plan, with respect to the Option or any portion thereof which has not become exercisable, the Option shall expire on the date the
Participant’s Employment is terminated for any reason, and with respect to any Option or any portion thereof which has become exercisable, the Option shall expire on the earliest to occur of (i) the commencement of business on the date the
Participant’s Employment is terminated for Cause; (ii) 30 days following the date the Participant resigns from Employment without Good Reason, (iii) 90 days after the date the Participant’s Employment is terminated by the Company
for any reason other than: for Cause, by reason of death or Disability or due to the Participant’s resignation from Employment with Good Reason; (iv) one year after the date the Participant’s Employment is terminated by reason of
death or Disability; or (v) the tenth anniversary of the Grant Date. For the avoidance of doubt, the Option, or portion thereof, that has become exercisable by a Permitted Transferee on account of the death of a Participant shall expire one
year after the date such deceased Participant’s Employment terminated by reason of death, and the Option or portion thereof that has been transferred to a Permitted Transferee during the lifetime of a Participant shall expire in connection with
the Participant’s termination of Employment at the time set forth under this Section 6 as if the Option were held directly by the Participant. Notwithstanding the foregoing, in the event that (a) the Participant is employed on the
Vesting Date applicable to any portion of his or her Performance Vesting Option, (b) the Participant’s Employment is terminated prior to the time at which the Board determines whether the EBITDA target applicable to such portion of
Participant’s Performance Vesting Option (and/or the EBITDA target for any Catch-Up Year) was met and (c) the Board subsequently determines that such EBITDA target was met, then the time period set forth in clause (ii), (iii) or
(iv) of the first sentence of this Section 6 (as applicable) shall begin to run with respect to such portion or portions of Participant’s Performance Vesting Option as of the date on which the Participant is notified that the Board
determined that the relevant EBITDA target was met rather than as of the date of termination of Participant’s Employment. In no event shall the Option remain outstanding for more than ten years following the Grant Date. 

7. Construction of Agreement. Any provision of this Agreement (or portion thereof) which is deemed invalid, illegal or
unenforceable in any jurisdiction shall, as to that jurisdiction and subject to this section, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions thereof in such
jurisdiction or rendering that or any other provisions of this Agreement invalid, illegal, or unenforceable in any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such
covenant shall be modified so that the scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid, legal and enforceable. No waiver of any provision or violation of this Agreement by the Company shall
be implied by the Company’s forbearance or failure to take action. No provision of this Agreement shall be given effect to the extent that such provision would cause any tax to become due under Section 409A of the Code; provided
that the Company shall use commercially reasonable efforts to put the Participants in the same position in which they would have been but for the application of this Section 7. 

  
 3 

 8. Delays or Omissions. No delay or omission to exercise any right, power or remedy
accruing to any party hereto upon any breach or default of any party under this Agreement, shall impair any such right, power or remedy of such party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein,
or of or in any similar breach or default thereafter occurring nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any
kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party or any provisions or conditions of this Agreement, shall be in writing and shall be effective only to the extent
specifically set forth in such writing. 
 9. Limitation on Transfer. The Option shall be exercisable only by the
Participant or the Participant’s Permitted Transferee(s), as determined in accordance with the terms of the Plan (including without limitation the requirement that the Participant obtain the prior written approval by the Board of any proposed
Transfer to a Permitted Transferee during the lifetime of the Participant). Each Permitted Transferee shall be subject to all the restrictions, obligations, and responsibilities that apply to the Participant under the Plan and this Stock Option
Grant Agreement and shall be entitled to all the rights of the Participant under the Plan, provided that in respect of any Permitted Transferee which is a trust or custodianship, the Option shall become exercisable and/or expire based on the
Employment and termination of Employment of the Participant. All shares of Common Stock obtained pursuant to the Option granted herein shall not be transferred except as provided in the Management Stockholders’ Agreement. 

10. Restrictive Covenants. 
 a. Confidentiality and Trade Secrets. By accepting an award under the Plan, Participant agrees to hold in strict confidence any proprietary or Confidential Information related to the Company and
its Affiliates. For purposes of this Agreement, the term “Confidential Information” shall mean all information of the Company or any of its Affiliates (in whatever form) which is not generally known to the public, including without
limitation any inventions, processes, methods of distribution, customer lists, customers’ secrets or Trade Secrets. For purposes of this Agreement, “Trade Secrets” shall mean all Confidential Information, including, without
limitation, formulae, patterns, compilations, programs, devices, methods, techniques, or processes, from which the Company or any of its Affiliates derives independent economic value, actual or potential, because such information is not generally
known to, or readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use and which the Company and its Affiliates make reasonable efforts to maintain secret. 

b. Non-Competition. Participant agrees that the Company would likely suffer significant and irreparable harm from
Participant’s competing with the Company or any of its Subsidiaries during the Participant’s Employment and for some period of time thereafter. Accordingly, by accepting an award under the Plan, Participant agrees that he or she will not,
during Participant’s Employment and for a period of twelve (12)

  
 4 

 
months following termination of his or her Employment, directly or indirectly perform Competitive Services (as defined below) for any person, firm, partnership, corporation, or other entity which
develops, manufactures, markets, distributes, or sells products materially similar to or competitive with those products developed, manufactured, marketed, distributed, or sold by the Company or any of its Subsidiaries or included in the business
plans of the Company or any of its Subsidiaries during the term of Participant’s Employment (any such person, firm, partnership, corporation, or other entity, a “Competitor”). For purposes of this Agreement,
“Competitive Services” means services provided to a Competitor: (A) which are substantially similar to those provided by Participant to the Company or any of its Subsidiaries during his or her employment with the Company or any
of its Subsidiaries; (B) where Participant’s direct or indirect use or disclosure of the Company’s or any of its Affiliates’ Confidential Information or Trade Secrets to or on behalf of the Competitor would provide the Competitor
with a competitive advantage; (C) where it is likely that as part of Participant’s capacity he or she would inevitably use or disclose any of the Company’s or any of its Affiliates’ Confidential Information or Trade Secrets;
(D) where Participant solicits, attempts to solicit, or engages in discussions or other communications with any past, present or potential customer of the Company or any of its Subsidiaries with whom Participant communicated or had any
interaction during the preceding eighteen (18) months with the purpose or intent of promoting, marketing, selling, or obtaining orders for any Competing Product; or (E) where Participant interferes adversely with any past, present, or
prospective business relationships between the Company or any of its Subsidiaries and any of their respective customers, potential customers, suppliers, distributors, agents, sales representatives, employees, independent contractors, or other
persons or entities with which the Company or any of its Subsidiaries conducts business. For purposes of this Agreement, “Competing Product” means any orthopedic product sold or intended to be sold by the Company or any of its
Subsidiaries and with which the Participant worked or was otherwise involved during the last two (2) years of Participant’s Employment. 
 c. Non-Solicitation. Participant agrees that the Company would likely suffer significant and irreparable harm from Participant’s solicitation of employees, distributors,
distributors’ sales representatives, sales representatives, customers, suppliers or vendors of the Company or any of its Subsidiaries during the Participants’ Employment and for some period of time thereafter. Accordingly, by accepting an
award under the Plan, Participant agrees that he or she will not, during Participant’s Employment and for a period of twelve (12) months following termination of his or her Employment, whether on his or her own behalf or on behalf of any
other Person, either directly or indirectly (i) hire, solicit, induce, persuade, or entice, or endeavor to solicit, induce, persuade, or entice any person who is then employed by or otherwise engaged to perform services for the Company or any
of its Subsidiaries to leave that employment or cease performing those services, (ii) solicit, induce, persuade, or entice, or endeavor to solicit, induce, persuade, or entice any Person who is a past or current customer, supplier, or vendor of
the Company or any of its Subsidiaries to cease being a customer, supplier, or vendor of the Company or any of its Subsidiaries or to divert all or any part of such Person’s business from the Company or any of its Subsidiaries or
(iii) solicit, induce, persuade, or entice, or endeavor to solicit, induce, persuade, or entice any distributor, sales representative or associate of the Company or any of its Subsidiaries to terminate their

  
 5 

 
relationship or association with the Company or any of its Subsidiaries or distributors, or do any act which may result in the impairment of the relationship between the Company or any of its
Subsidiaries and their respective agents, employees, consultants, representatives or distributors. 
 d.
Company’s Remedies for Violation of Non-Competition or Non-Solicitation Covenant. In the event that either the Participant’s Employment with the Company is terminated for Cause or the Participant violates any of the restrictive
covenants set forth in Section 10(a), Section 10(b) or Section 10(c): 
 i. All Options held by
such Participant, whether vested or unvested, shall be immediately canceled as of the commencement of business on the date on which the Participant’s Employment is terminated for Cause or the first date on which such violation occurs;

 ii. In either case prior to the Agreement Termination Date, the Company (or its designated assignee) shall
have (A) the call rights, with respect to shares of Common Stock held by the Participant (including shares acquired through the exercise of Options under the Plan), that are set forth in Section 3(b)(ii)(A) of the Management
Stockholders’ Agreement and (B) the right to receive from the Participant the payments described in Section 3(b)(v) of the Management Stockholders’ Agreement (if any); and 

iii. In either case, following the Agreement Termination Date, the Participant shall be obligated to pay to the Company as
liquidated damages, in addition to all other rights and remedies the Company may have, an amount equal to the amount which the Participant will be required to recognize in income for U.S. federal income tax purposes as a result of such
Participant’s exercise of Options at any time following, or within one year prior to, the date of termination of his or her Employment. 
 e. Remedies. Except as provided in Section 10(f), the Company’s sole recourse under the Plan against the Participant for any violation by the Participant of any of the restrictive
covenants set forth in Section 10(b) or Section 10(c) shall be the rights and remedies described in Section 10(d). The Company’s rights under Section 10(d) shall be in addition to, and shall not in any way prejudice the
Company with respect to, any other rights and remedies the Company may have in the event of any violation by the Participant of the restrictive covenants set forth in Section 10(a). 

f. Payment for Compliance with Non-Competition and Non-Solicitation Covenants. 

i. The Participant hereby agrees that if his or her Employment with the Company is terminated for any reason: (i) the
Company shall have the right (which it may exercise or not exercise in its sole discretion in accordance with Section 10(f)(ii) hereof) to (A) continue paying the Participant his or her base salary (as in effect on the date of termination
of the Participant’s Employment), in 

  
 6 

 
accordance with the Company’s normal payroll practices, for a period not to exceed twelve (12) months following the date of termination of the Participant’s Employment (the
“Salary Continuation Period”) and (B) pay the Participant an amount equal to the product of (x) the lesser of the annual bonus the Participant received for the year immediately preceding the year in which the
Participant’s employment is terminated (if any) or the Participant’s target annual bonus for the year in which the Participant’s employment is terminated (if any) and (y) a fraction, the numerator of which is the number of whole
calendar months in the Salary Continuation Period and the denominator of which is twelve (12), which amount shall be paid in installments over the course of the Salary Continuation Period in accordance with the Company’s normal payroll
practices (such salary and bonus payments, the Participant’s “Non-Compete Compensation”) and (ii) during the Salary Continuation Period (if any), the Participant shall be bound by, and shall comply with the provisions of,
Section 10(b) and Section 10(c) hereof. The Company’s rights under this Section 10(f) shall be in addition to, and shall not in any way prejudice the Company with respect to, its rights under Section 10(d) hereof. For the
avoidance of doubt, the Participant shall remain bound by the provisions of Section 10(a) hereof regardless of whether or not the Company exercises its rights under this Section 10(f). 

ii. In the event that a Participant’s Employment is terminated by the Participant or the Company as described in
Section 10(f)(i) hereof, the Company automatically shall be deemed to exercise its rights under this Section 10(f) and the Salary Continuation Period for such Participant shall be deemed to be twelve (12) months following the date of
termination of the Participant’s Employment, unless the Company notifies the Participant, within thirty (30) business days following the effective date of termination of the Participant’s Employment, either that it will not exercise
its rights under this Section 10(f) or that the length of the Salary Continuation Period for such Participant shall be less than twelve (12) months. 
 iii. The Company in its sole discretion may elect, at any time during the Salary Continuation Period, to discontinue the Salary Continuation Period by notifying the Participant in writing at least thirty
(30) business days prior to the date on which the Salary Continuation Period will terminate. If the Company elects to discontinue the Salary Continuation Period as described in the preceding sentence, then the Participant shall cease to be
bound by the provisions of Section 10(b) and Section 10(c) hereof as of the date on which the Salary Continuation Period terminates. 
 iv. Notwithstanding anything in the Plan or this Agreement to the contrary, in the event that the Participant violates any provision of Section 10(b) or Section 10(c) during the Salary
Continuation Period, (A) the Company shall immediately cease paying the Participant the Non-Compete Compensation and (B) the Participant shall nonetheless remain bound by the provisions of Section 10(b) and Section 10(c) hereof
for the remainder of the period during which he or she would have been bound by such obligations if no such violation had occurred. 

  
 7 

 g. The restrictive covenants set forth in Sections 10(a), 10(b) and 10(c)
hereof shall be in addition to, and nothing in this Section 10 (including, without limitation, the Company’s rights under Section 10(f) hereof and any election by the Company to exercise or not exercise such rights) shall in any way
prejudice the Company’s rights with respect to, any restrictive covenants and confidentiality obligations (or similar restrictions and obligations) in favor of the Company which are applicable to the Participant by law, in equity, or under any
other plan, program, agreement or arrangement with the Company (including, without limitation, the Participant’s common law obligations with respect to the Company’s confidential information). 

h. The Participant recognizes that a breach or threatened breach of the restrictive covenants set forth in Sections 10(a),
10(b) and 10(c) hereof may give rise to irreparable injury to the Company, inadequately compensable in damages. Accordingly, the Participant agrees that in the event of a breach or threatened breach of the restrictive covenants set forth in
Section 10(a) hereof or, during the Salary Continuation Period (if any), Section 10(b) or Section 10(c) hereof, the Company may seek and obtain injunctive relief, temporary, preliminary or permanent, against such breach or threatened
breach, in addition to recovering any monetary damages from the Participant. The Participant further agrees and acknowledges that greater injury would likely result by refusing the Company or its successors or assigns injunctive relief than by
granting such injunctive relief. The Participant hereby waives any right to require the Company to obtain a bond in connection with any such injunctive proceedings. The Company shall also be entitled to recover from the Participant its reasonable
attorneys’ fees and costs of any action that it successfully brings against the Participant for any breach or threatened breach described in this Section 10(h). 

i. The restrictive covenants set forth in this Section 10 shall be binding upon, and shall inure to the benefit of,
the Company, its Affiliates and their respective successors and assigns. By accepting an award under the Plan, the Participant agrees that the Company shall have the right to assign any or all of its rights hereunder to any successor in interest,
whether by merger, consolidation, sale of assets, public offering, or otherwise. 
 j. Notwithstanding anything
to the contrary in the Plan or this Agreement, the construction, enforceability and interpretation of this Section 10 shall be governed by the laws of the state in which the Participant’s employer operates its principal place of business.
Except as expressly provided herein, the failure of the Company to insist upon performance of any of the provisions of this Section 10 or to pursue its rights hereunder shall not be construed as a waiver of any such provisions or the
relinquishment of any such rights. The Participant further agrees that any legal action relating to this Section 10 shall be commenced and maintained exclusively before any appropriate venue located in the local, county or federal court in
which the Participant’s employer operates its principal place of business. Participants hereby submit to the jurisdiction of such courts and waive any right to challenge or otherwise object to personal jurisdiction or venue, in any action
commenced or maintained in such courts. 

  
 8 

 11. Integration. This Agreement, and the other documents referred to herein or
delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to its subject matter. There are no restrictions, agreements, promises, representations, warranties, covenants or undertakings with
respect to the subject matter hereof other than those expressly set forth herein and in the Plan. The Participant hereby acknowledges that this Agreement, the Plan and the Management Stockholders’ Agreement supersede all prior agreements and
understandings between the parties with respect to the subject matter of this Agreement, including without limitation, any provision in such prior agreement or understanding, including without limitation any change of control agreement, that
provides for the acceleration or waiver of any time periods, conditions or contingencies relating to the exercise or realization of, or lapse of restrictions under, any outstanding equity award held by the Participant. 

12. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which shall constitute one and the same instrument. 
 13. Governing Law. Except as expressly provided in
Section 10(j) hereof, this Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without regard to the provisions governing conflict of laws. 

14. Participant Acknowledgment. The Participant hereby acknowledges receipt of a copy of the Plan. The Participant hereby
acknowledges that all decisions, determinations and interpretations of the Board in respect of the Plan, this Agreement and the Option shall be final and conclusive. The Participant further acknowledges that, prior to the Agreement Termination Date,
no exercise of the Option or any portion thereof shall be effective unless and until the Participant has executed the Management Stockholders’ Agreement and the Participant hereby agrees to be bound thereby. 

[Signature page follows] 

  
 9 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be duly executed by its duly
authorized officer and said Participant has hereunto signed this Agreement on his own behalf, thereby representing that he has carefully read and understands, and agrees to be bound by, this Agreement, the Plan and the Management Stockholders’
Agreement as of the day and year first written above. 
  

									
	LVB Acquisition, Inc.	 		 	Participant
					
		 	 	 		 		 	
	By:	 	Bradley J. Tandy	 		 	Name:	 	 
	 Title:
	 	Senior Vice President,	 		 		 	
		 	General Counsel and Secretary	 		 	Date:	 	 

  
 10Management Equity Incentive Plan Addendum I: Leveraged Share Purchase Program

 Exhibit 10.8.3 
 LVB ACQUISITION, INC. 
 MANAGEMENT EQUITY INCENTIVE PLAN 

ADDENDUM I: 
 LEVERAGED SHARE PURCHASE PROGRAM 
 Adopted March 18, 2008 (the
“Effective Date”) 
 A. Purpose of this Addendum 

The purpose of the Leveraged Share Purchase Program (the “Program”) under the LVB Acquisition, Inc. Management Equity Incentive Plan (the
“Plan”) is to promote the interests of the Company and its Affiliates and stockholders by providing certain key employees, directors, service providers and consultants of the Company and its Affiliates who are located in certain
non-US jurisdictions with an appropriate incentive to encourage them to continue in the employ of the Company or an Affiliate and to improve the growth and profitability of the Company. The Program shall be governed by the terms and conditions set
forth in this Leveraged Share Purchase Program Addendum to the Plan (the “Addendum”) and, except as expressly modified herein, the Plan. References herein to the Plan shall be construed to refer to the Plan as expressly modified
herein. 
 With respect to a Participant in the Program, where applicable, references in the Plan to: 

(1) “Participants” shall be construed to refer to a Participant as defined herein. 

(2) “Options” (whether or not capitalized) shall be construed to refer to Awards granted under the Program or Leveraged Shares
purchased pursuant thereto (as applicable), 
 (3) “Grant” and “Grant Date” shall be construed to refer to a
Grant or Grant Date, respectively, as defined herein, 
 (4) “Stock Option Grant Agreements” shall be construed to
refer to Award Grant Agreements as defined herein, 
 (5) the “Exercise Price” (whether or not capitalized) of Options
(whether or not capitalized) shall be construed to refer to the Share Purchase Price for shares underlying Awards granted pursuant to the Program, 
 (6) the vesting of Options shall be construed to refer to the Vesting of Leveraged Shares as defined herein, 

 (7) the exercise of Options shall be construed to refer to the Participant’s payment of
the Repayment Amount for Leveraged Shares, 
 (8) the cancellation of Options shall be construed to refer the forfeiture of
Leveraged Shares; 
 (9) “U.S. federal income tax” shall be construed, with respect to a Participant, to refer to any
applicable income tax imposed by the national government in the country in which such Participant resides. 
 B. Definitions

 As used in this Addendum, the following capitalized terms shall have the meanings set forth next to such terms below. All capitalized
terms used but not defined herein shall have the meanings given to such terms in the Plan. 
 (1) “Associated
Loan” shall mean, with respect to a Leveraged Share, the Loan proceeds used on behalf of the Participant to purchase such Leveraged Share (together with interest, where applicable). 

(2) “Award” shall mean a leveraged equity award granted to a Participant under the Program, pursuant to which the
Participant shall have the right to purchase a specified number of shares of Common Stock and in connection with which the Company shall extend to the Participant a Loan in the principal amount equal to the product of the applicable Share Purchase
Price and the number of shares subject to such Award, the proceeds of which the Participant shall use to purchase the shares subject to his or her Award, in each case subject to the terms and conditions set forth in this Addendum and the applicable
Award Grant Agreement. References herein to “Awards” will be deemed to include “Time Based Awards,” “Hurdle Awards,” and “Performance Based Awards.” 

(3) “Award Grant Agreement” shall mean an agreement, substantially in the form which is attached hereto as Appendix A,
entered into by each Participant and the Company evidencing the Grant of an Award pursuant to the Plan. 
 (4) “Early
Repayment” shall have the meaning given to such term in Section D(12)(b) hereof. 
 (5) “Executive
Officer” shall mean a director or officer (or equivalent thereof) of the Company within the meaning of 
 Section 13(k) of the
Exchange Act, as amended from time to time, and the rules and regulations promulgated thereunder, as in effect from time to time. 
 (6) “Forfeiture Date” shall have the meaning given to such term in Section D(11) hereof. 

  
 2 

 (7) “Grant” shall mean a grant of an Award under the Program evidenced by
an Award Grant Agreement. 
 (8) “Grant Date” shall mean the date designated by the Board and specified in the
Award Grant Agreement as of the date the Award is granted. 
 (9) “Hurdle Award” shall mean an Award pursuant
to which the Participant shall be entitled to purchase Leveraged Shares (a) with respect to which the Associated Loan shall accrue interest at the Hurdle Award Interest Rate and (b) which shall Vest with respect to one-fifth (1/5) of
the Leveraged Shares purchased pursuant to such Award on each of the first through fifth anniversaries of the Grant Date, or such other dates as may be set forth in the applicable Award Agreement, subject to the Participant’s continued
Employment through each such Vesting Date. 
 (10) “Hurdle Award Interest Rate” shall mean, with respect to an
Associated Loan granted in connection with a Leveraged Share purchased pursuant to a Hurdle Award, an interest rate of 10.00% compounded annually on each anniversary of the Grant Date of such Hurdle Award or such other dates as may be specified in
the applicable Award Grant Agreement, until the earliest to occur of (i) repayment of the Associated Loan granted in connection with such Leveraged Share, (ii) the fifth anniversary of the Grant Date of such Hurdle Award, or such other
date as may be specified in the applicable Award Grant Agreement, or (iii) the occurrence of a Change of Control; provided, however, that interest shall cease to accrue as provided herein on the Associated Loans granted in connection
with a pro rata portion of the Leveraged Shares purchased pursuant to each outstanding Hurdle Award following any sale by the Majority Stockholder of shares of Common Stock as follows: the number of Leveraged Shares purchased pursuant to each
outstanding Hurdle Award with respect to which the Associated Loan shall cease to accrue interest shall be the number of shares that bears the same ratio to the total number of Leveraged Shares purchased pursuant to such Hurdle Award on the Grant
Date as the total number of shares of Common Stock directly or indirectly sold by the Majority Stockholder bears to the total number of shares of Common Stock owned by the Majority Stockholder immediately after the Closing (reduced by any shares
transferred by a Majority Stockholder to executives, employees, consultants directors and other service providers prior to the first anniversary of the Closing and excluding for this purpose shares transferred by a Majority Stockholder to an
Affiliate of such Majority Stockholder). 
 (11) “Hurdle Shares” shall mean Leveraged Shares purchased pursuant
to a Hurdle Award. 
 (12) “Leveraged Shares” shall have the meaning given to such term in Section D(4) hereof.
For the avoidance of doubt, upon repayment in full of the Associated Loan (with interest, if applicable) in accordance with the terms set forth herein, a share purchased on behalf of a Participant pursuant to Section D(4) hereof shall cease to be a
Leveraged Share and shall thereafter be referred to as a Restricted Share or a Released Share, as applicable. 

  
 3 

 (13) “Loan” shall mean a non-recourse loan made by the Company to the
Participant in connection with an Award, the proceeds of which shall be used by the Participant solely to purchase the shares of Common Stock underlying such Award. Except for the Associated Loans granted in connection with Leveraged Shares
underlying Hurdle Awards, which shall accrue interest at the Hurdle Award Interest Rate, Loans made to Participants pursuant to the Program shall be interest-free. 
 (14) “Participant,” for purposes of this Addendum, shall mean an Eligible Employee (as that term is defined in the Plan), other than an Executive Officer (except as expressly provided
herein), to whom an Award has been granted pursuant to the Program and, where applicable, shall include Permitted Transferees. 

(15) “Performance Based Award” shall mean an Award pursuant to which the Participant shall be entitled to purchase
Leveraged Shares that shall Vest based on the achievement of EBITDA targets to be established by the Board in consultation with the Chief Executive Officer of Biomet, Inc. and set forth in the applicable Award Agreement; provided that
(i) if any Leveraged Share purchased pursuant to a Performance Based Award does not Vest during a fiscal year, such Leveraged Share shall remain outstanding until terminated in accordance with its terms and shall be subject to the achievement
of cumulative performance targets (which will include the performance targets established for the following fiscal years) during the term of the Performance Based Award, as determined by the Board and set forth in the applicable Award Agreement; and
(ii) if: 
 (A) the Company achieves 97% of its annual EBITDA target for any fiscal year (any such fiscal year, a
“97% Target Year”); and 
 (B) either: 

(I) a Liquidity Event subsequently occurs in which the Majority Stockholder realizes an MoM that is (x) at least 2.0
if the Liquidity Event occurs on or prior to the fourth anniversary of the Closing or (y) at least 2.5 if the Liquidity Event occurs after the fourth anniversary of the Closing; or 

(II) (1) an Initial Public Offering has occurred, (2) the Majority Stockholder has sold directly or indirectly, in
one or more Liquidity Event(s), 80% or more of the Initial Majority Stockholder Shares (determined based on the number of the Initial Majority Stockholder Shares as of the Closing date) and (3) the Majority Stockholder has realized directly or
indirectly in such Liquidity Event(s) an MoM that is at least 2.5, provided that MoM for this purpose shall be determined by multiplying clause (ii) of Section 2(dd) of the Plan by a fraction, the numerator of which is the number of
Initial Majority Stockholder Shares disposed of in all such Liquidity Events and the denominator of which is equal to the number of the Initial Majority Stockholder Shares as of the Closing date; 

then any Leveraged Shares purchased pursuant to a Performance Based Award which initially became eligible to vest based on the achievement of the annual
EBITDA target applicable to a 97% Target Year and which remain unvested as of the date on which the Liquidity Event occurs (or, in the case of clause II above, the later of the date on which the Liquidity Event occurs or the

  
 4 

 
fifth anniversary of the Closing), shall immediately vest upon the occurrence of the Liquidity Event (or, in the case of clause II above, the later of the date on which the Liquidity Event occurs
or the fifth anniversary of the Closing), provided the Participant is Employed on such vesting date. 
 (16)
“Performance Based Shares” shall mean Leveraged Shares purchased pursuant to a Performance Based Award. 
 (17)
“Released Shares” shall have the meaning given to such term in Section D(11) or Section D(12)(d) hereof, as applicable. For the avoidance of doubt, (a) upon repayment in full of the Associated Loan (with interest, if
applicable) in accordance with Section D(11) hereof, a share purchased on behalf of a Participant pursuant to Section D(4) hereof shall cease to be a Leveraged Share and shall thereafter be referred to as a Released Share and (b) upon
expiration of the Restriction Period applicable to a Restricted Share in accordance with Section D(12)(c) hereof, such share shall cease to be a Restricted Share and shall thereafter be referred to as a Released Share. 

(18) “Repayment Amount” shall mean, with respect to a Leveraged Share, the amount of the Associated Loan, which shall be
equal to the applicable Share Purchase Price for such Leveraged Share plus, in the case of a Leveraged Share purchased pursuant to a Hurdle Award, the interest that has accrued on such Associated Loan as of the Repayment Date. 

(19) “Repayment Date” shall have the meaning given to such term in Section D(13) hereof. 

(20) “Repayment Notice” shall have the meaning given to such term in Section D(13) hereof. 

(21) “Restricted Share” shall have the meaning given to such term in Section D(12)(c) hereof. For the avoidance of
doubt, (a) upon repayment in full of the Associated Loan (with interest, if applicable) in accordance with Section D(12) hereof, a share purchased on behalf of a Participant pursuant to Section D(4) hereof shall cease to be a Leveraged Share
and, prior to the expiration of the Restriction Period applicable to such share, shall be referred to as a Restricted Share and (b) upon expiration of the Restriction Period applicable to a Restricted Share in accordance with Section D(12)(c)
hereof, such share shall cease to be a Restricted Share and shall thereafter be referred to as a Released Share. 
 (22)
“Security Interest” shall have the meaning given to such term in Section D(5) hereof. 
 (23) “Share
Purchase Price” shall mean the purchase price per share of Common Stock underlying an Award, as determined by the Board and initially specified in the Award Grant Agreement for such Award, subject to any increase or other adjustment that
may be made following the Grant Date pursuant to the Plan or this Addendum. 

  
 5 

 (24) “Time-Based Award” shall mean an Award pursuant to which the
Participant shall be entitled to purchase Leveraged Shares that shall Vest with respect to one-fifth (1/5) of the Leveraged Shares purchased pursuant to the Award on each of the first through fifth anniversaries of the Grant Date, or other such
dates as may be set forth in the applicable Award Agreement, subject to the Participant’s continuous Employment through each Vesting Date. 
 (25) “Time Based Shares” shall mean Leveraged Shares purchased pursuant to a Time Based Award. 
 (26) “Unvested” shall mean, with respect to a Leveraged Share, that such share has not yet Vested. 
 (27) “Vest” shall mean, with respect to a Leveraged Share, that the Associated Loan shall become repayable, subject in all cases to the Participant’s continuous Employment through
the applicable Vesting Date. “Vesting” and “Vested” shall have correlative meanings. 
 (28)
“Vesting Date” shall mean, with respect to a Leveraged Share, the date on which such Leveraged Share Vests pursuant to this Addendum. 
 C. Administration of the Program 
 The Program shall form a part of
the Plan and shall be administered by the Board or a committee thereof pursuant to Section 3 of the Plan. 
 D. Awards

 Subject to adjustment as provided in Section 4.13 of the Plan, the Board may grant to Participants Awards
pursuant to which such Participants may purchase a total number of shares of Common Stock of the Company which, when aggregated with the total number of shares of Common Stock underlying Options granted pursuant to Section 4 of the Plan, do not
exceed 37,520,000 shares of Common Stock. With respect to each Award made to a Participant under the Program, unless otherwise specified in the Award Grant Agreement evidencing such Award, fifty percent (50%) of the Award will be a Time Based
Award, twenty-five percent (25%) of the Award will be a Performance Based Award and twenty-five percent (25%) of the Award will be a Hurdle Award. To the extent that any Leveraged Share purchased by a Participant pursuant to an Award is
forfeited pursuant to this Addendum, the Plan or the applicable Award Grant Agreement, or transferred to the Company pursuant to Section D(15) hereof, such share shall again be available for granting Awards pursuant to the Program and/or Options
pursuant to the Plan. 
 (1) Share Purchase Price. The Share Purchase Price applicable to the shares of Common
Stock underlying an Award granted pursuant to the Program shall be such price as the Board shall determine and shall specify in the Award Grant Agreement (provided that such Share Purchase Price must not be less than the minimum price
required by the laws of the jurisdiction in which the Participant receiving the Award resides). 

  
 6 

 (2) Grant Date. The Grant Date of an Award shall be the date designated by the Board
and specified in the applicable Award Grant Agreement as of the date on which the Award is granted. 
 (3) Loans to
Participants. On the Grant Date, the Company shall extend to each Participant a Loan in the principal amount equal to the product of the applicable Share Purchase Price and the number of shares of Common Stock subject to the Award, as specified
in the Award Grant Agreement for such Award. With respect to Loans granted in connection with Hurdle Shares, such Loans shall accrue interest at the Hurdle Award Interest Rate. Loans granted in connection with the shares underlying all Awards other
than Hurdle Awards shall be interest-free. The proceeds of the Loan shall not be transferred to the Participant, but shall be automatically applied to purchase, on the Participant’s behalf and in accordance with Section D(4) hereof, the shares
subject to the Participant’s Award. In consideration of the Company’s extension of the Loan to the Participant, the Participant shall pledge the shares purchased on his or her behalf pursuant to the Award as collateral for the Loan in
accordance with Section D(5) hereof. 
 (4) Purchase of Shares. On (or as soon as reasonably practicable
following) the Grant Date, the Company shall, on behalf of the Participant, apply the proceeds of the Participant’s Loan to purchase for the Participant the number of shares subject to the Participant’s Award, as specified in the
applicable Award Grant Agreement. The Participant’s ownership of the shares of Common Stock so purchased (the “Leveraged Shares”) shall be recorded in a book-entry or similar system utilized by the Company as soon as reasonably
practicable following the Grant Date. Prior to the Agreement Termination Date, no shares of Common Stock shall be issued to or recorded in the name of any Participant or Permitted Transferee until such Participant or Permitted Transferee agrees to
be bound by and executes the Management Stockholders’ Agreement. The Participant shall be responsible for the payment of applicable withholding and other taxes, if any, in cash (or shares of Common Stock if approved by the Board) that may
become due as a result of the purchase of the shares underlying the Award. 
 (5) Pledge of Shares. As collateral
security for the full and timely payment of all amounts due with respect to a Participant’s Loan, the Participant shall pledge and grant to the Company a first priority continuing security interest and lien in and right of setoff against all of
the Participant’s right, title and interest in the Leveraged Shares, any rights relating thereto and any proceeds therefrom (the “Security Interest”). The Employee further agrees to execute or cause to be executed such
documents and to take or cause to be taken such other actions, if any, as are required to create for the Company a first priority perfected security interest in the Security Interest. Participant has to date not taken any action to, and shall not,
sell, assign, transfer or otherwise dispose of, or grant any option with respect to, or pledge or otherwise encumber (except pursuant to this Addendum and the applicable Award Grant Agreement) the Security Interest without the written consent of the
Company. The Company shall have all the rights and remedies of a secured party under the Uniform Commercial Code as in effect from time to time in the State of New York. Except for the Company’s rights pursuant to the Security Interest, the
Loan granted to a Participant in connection with his or her Award shall be non-recourse to the Participant. 

  
 7 

 (6) Vesting of Awards. 

(a) Vesting. Each Award Grant Agreement shall indicate the date(s) on and/or condition(s) under which the Leveraged Shares
purchased pursuant thereto shall Vest. Unless the Committee provides otherwise, the Vesting of Leveraged Shares purchased under the Program may be suspended during any leave of absence as may be set forth by Company policy, if any. 

(b) Accelerated Vesting on a Qualifying Termination. In the event that a Participant’s Employment is terminated by the
Company without Cause or by the Participant for Good Reason during the two (2)-year period following a Change of Control of the Company, all of the Participant’s Time Based Shares, Hurdle Shares and shares that have been converted into
time-based vesting shares in accordance with Section D(6)(c) below, if any, shall immediately Vest as of the date of such termination of Employment. 
 (c) Accelerated Vesting on a Change of Control. In the event that, prior to the fifth anniversary of the Grant Date, a Change of Control of the Company occurs which results in the Majority
Stockholder realizing directly or indirectly an amount in cash equal to the greater of (i) an MoM of at least 2.0 or (ii) an internal rate of return (including all cash and the market value of all marketable securities received in
connection with such Change of Control and all cash dividends and other distributions to the Majority Stockholders in respect of the Initial Majority Stockholder Shares prior to the Change of Control) of at least 20%, then all of the
Participant’s Performance Based Shares which, as of the date of the Change of Control, have not yet become eligible to Vest by virtue of the annual EBITDA targets applicable to such Performance Based Shares shall be automatically converted into
time-based vesting shares and shall Vest (based solely on the passage of time and without regard to any EBITDA targets) on the date on which such shares would have vested if (x) no Change of Control had occurred and (y) the Company had
achieved the annual EBITDA targets applicable to such Performance Based Shares. 
 (7) Forfeiture of Leveraged
Shares. All Leveraged Shares, whether or not Vested, shall be forfeited by the Participant on the earlier to occur of (x) the first date on which both (i) the Company is or becomes subject to the prohibition on loans to directors
and executive officers set forth in Section 13(k) of the Exchange Act (or any successor statute) and (ii) the Participant is or becomes an Executive Officer or (y) the tenth anniversary of the Grant Date of the Award pursuant to which
such shares were purchased, unless such shares are forfeited earlier as provided below. With respect to each Participant, such Participant’s Leveraged Shares which have not yet Vested shall be forfeited by the Participant on the date his or her
Employment is terminated for any reason unless otherwise specified herein or in the applicable Award Grant Agreement. With respect to each Participant, such Participant’s Leveraged Shares which have Vested on or before the date his or her
Employment is terminated shall, unless otherwise provided in the applicable Award Grant Agreement, be forfeited by the Participant on the earliest to occur of (i) the commencement of business on the date the Participant’s Employment is
terminated for Cause; (ii) 30 days following the date the Participant resigns from Employment without Good Reason, (iii) 90 days after the date the Participant’s Employment is terminated by the Company for any reason other than Cause,
death, Disability or the Participant’s resignation 

  
 8 

 
from Employment with Good Reason; (iv) one year after the date the Participant’s Employment is terminated by reason of death or Disability; or (iv) the tenth anniversary of the
Grant Date of the Award(s) pursuant to which such Leveraged Shares were purchased. For the avoidance of doubt, any Vested Leveraged Shares held by a Permitted Transferee on account of the death of a Participant shall be forfeited by such Permitted
Transferee one year after the date such deceased Participant’s Employment terminated by reason of death, unless otherwise provided in the applicable Award Grant Agreement, and any Leveraged Shares that have been transferred to a Permitted
Transferee during the lifetime of a Participant shall be forfeited by the Participant in connection with the Participant’s termination of Employment at the time set forth under this Section D(7) as if the Leveraged Shares were held directly by
the Participant, unless otherwise provided in the applicable Award Grant Agreement. Notwithstanding the foregoing, the Board may specify in the Award Grant Agreement a different forfeiture date or period for any Leveraged Shares purchased hereunder,
and such forfeiture date or period shall supersede the foregoing forfeiture date or period (provided that in no event shall any Leveraged Share remain outstanding for more than ten years following the Grant Date of the Award pursuant to which such
share was purchased). For the avoidance of doubt, the forfeiture provisions of this Section D(7) shall apply only with respect Leveraged Shares and not with respect to Restricted Shares or Released Shares. 

(8) Limitation on Transfer. All Awards granted to a Participant, and all Leveraged Shares and Restricted Shares purchased
pursuant thereto, shall be non-transferable, and the shares underlying a Participant’s Awards may be purchased only by the Participant, except that a Participant may assign or transfer his or her rights with respect to any or all of the Awards,
Leveraged Shares and Restricted Shares held by such Participant to: (i) such Participant’s beneficiaries or estate upon the death of the Participant and (ii) subject to the prior written approval by the Board (unless otherwise
provided in the applicable Award Grant Agreement), and subject to compliance with all applicable tax, securities and other laws, any trust or custodianship created by the Participant, the beneficiaries of which may include only the Participant, the
Participant’s spouse or the Participant’s lineal descendants (by blood or adoption), (each of (i) and (ii), a “Permitted Transferee”). 
 (9) Condition Precedent to Transfer of Any Award. It shall be a condition precedent to any Transfer of any Award, Leveraged Shares or Restricted Share by any Participant that the Transferee,
if not already a Participant in the Program, shall agree prior to the Transfer in writing with the Company to be bound by the terms of the Plan, this Addendum, the Award Grant Agreement and the Management Stockholder’s Agreement as if he or she
had been an original signatory thereto, except that any provisions of the Plan or this Addendum based on the Employment (or termination thereof) of the original Participant shall continue to be based on the Employment (or termination thereof) of the
original Participant. 
 (10) Effect of Void Transfers. In the event of any purported Transfer of any Award,
Leveraged Shares or Restricted Shares in violation of the provisions of the Plan or this Addendum, such purported Transfer shall, to the extent permitted by applicable law, be void and of no effect. 

  
 9 

 (11) Repayment of Loans. At any time on or after the
Vesting Date of a Leveraged Share and prior to the date on which such Leveraged Share is forfeited in accordance with the terms of this Addendum, the Plan and/or the applicable Award Grant Agreement (the “Forfeiture Date”), the
Participant shall be permitted to pay to the Company the Repayment Amount for such Leveraged Share. Upon the Participant’s payment to the Company of the Repayment Amount for a Leveraged Share pursuant to this Section D(11), the Company’s
Security Interest in such share shall terminate (such share thereafter, a “Released Share”). For purposes of the Management Stockholders’ Agreement, a share purchased pursuant to an Award under the Program shall be deemed to be
“held” by the Participant (or his or her Transferee (as defined in the Management Stockholders’ Agreement)) beginning as of the date on which such share becomes a Released Share. 

(12) Executive Officers. 
 (a) In the event that the Company determines in its discretion: 
 (i) in the case
of any Participant who is an Executive Officer, that the Company is expected to become subject to the prohibition on loans to directors and executive officers set forth in Section 13(k) of the Exchange Act (or any successor statute) and

 (ii) in the case of any Participant who is not an Executive Officer, that he or she is expected to become an Executive Officer
at a time when the Company is or is expected to become subject to the prohibition on loans to directors and executive officers set forth in Section 13(k) of the Exchange Act (or any successor statute), 

then the Company shall notify such Participant that he or she may exercise the rights set forth in this Section D(12). 

(b) During the period beginning on the date the Company provides notice to the Participant as described in the Section 12(a) and
ending upon the commencement of business on (i) the date on which the Company becomes subject to Section 13(k) of the Exchange Act as described in Section 12(a)(i) or (ii) the date on which such Participant becomes an Executive
Officer as described in Section 12(a)(ii), as applicable, (A) with respect to each Vested Leveraged Share, the Participant shall be permitted to exercise his or her rights pursuant to Section D(11) and (B) with respect to each
Unvested Leveraged Share, the Participant shall be permitted to pay to the Company the Repayment Amount for such Leveraged Share (such payment with respect to any Unvested Leveraged Share, “Early Repayment”), subject to the
provisions of this Section D(12). 
 (c) Upon the Participant’s Early Repayment with respect to an Unvested Leveraged Share
(such share thereafter, a “Restricted Share”): 
 (i) the Company’s Security Interest in such share shall
terminate and 
 (ii) prior to the date on which such share would have Vested (or, in the case of a Performance Based Share,
expired without Vesting) if not for the operation of this Section D(12) and clause (x) of Section D(7) (such period, the “Restriction Period”), if the Participant’s Employment is terminated

  
 10 

 
for any reason, the Company (or its designated assignee) shall have the right to purchase from the Participant, and upon the exercise of such right the Participant shall sell to the Company (or
its designated assignee), all or any portion of the Restricted Shares held by the Participant on the date as of which such right is exercised at a per share price equal to the lesser of (A) the Fair Market Value of such share on the date as of
which such right is exercised or (B) the Repayment Amount paid by the Participant with respect to such share. 
 (d) Upon
termination of the Restriction Period applicable to a Restricted Share, such share shall cease to be a Restricted Share and shall become a “Released Share.” For purposes of the Management Stockholders’ Agreement, a share
purchased pursuant to an Award under the Program shall be deemed to be “held” by the Participant (or his or her Transferee (as defined in the Management Stockholders’ Agreement)) beginning as of the date on which such share becomes a
Released Share. 
 (13) Method of Repayment. The Participant may pay the Repayment Amount for any Vested Leveraged
Share, and any Leveraged Share eligible for Early Repayment pursuant to Section D(12), by delivery of written notice to the Company’s principal office (the “Repayment Notice”), to the attention of its Secretary, no less than
two business days in advance of the effective date of the proposed repayment (the “Repayment Date”). Such notice shall be signed by the Participant or his or her Permitted Transferee and shall specify the Repayment Amount and the
number of Leveraged Shares with respect to which the Associated Loan is being repaid, the Grant Date of the Award pursuant to which the Leveraged Shares were purchased, and the Repayment Date. The Repayment Notice shall include payment in cash (or
any method otherwise approved by the Board) in an amount equal to (a) the product of the Share Purchase Price applicable to the Leveraged Shares with respect to which the Associated Loan is being repaid and the number of Leveraged Shares with
respect to which the Associated Loan is being repaid, as specified in such Repayment Notice, plus (b) in the case of a Leveraged Share purchased pursuant to a Hurdle Award, the interest that has accrued on the Associated Loan as of the
Repayment Date. In addition, the Participant shall be responsible for the payment of applicable withholding and other taxes, if any, in cash (or shares of Common Stock if approved by the Board) that may become due as a result of the repayment of
such Loan. The Board may, in its discretion, permit Participants to make the above-described payments in forms other than cash. In addition, in the event that a Participant’s Employment terminates due to death or Disability or is terminated by
the Company without Cause or by the Participant for Good Reason or as otherwise provided in a Award Grant Agreement, the Company will permit such Participant to repay all or any portion of his or her then-repayable Loan with shares of Common Stock
(to satisfy both the Repayment Amount and applicable withholding taxes (at the minimum statutory withholding rate), if any; provided that the Company’s Chief Financial Officer makes a good faith determination at such time and after
reasonable efforts to consult with the Company’s independent auditors that payment of the Repayment Amount in shares would not produce materially less favorable tax or accounting consequences for the Company than if such amount were paid in
cash. A partial repayment of the Loan, alone, shall not cause the expiration, termination or cancellation of the remainder of the Loan or the forfeiture of any Leveraged Shares with respect to which the Associated Loan has not yet been repaid.

  
 11 

 (14) Certificates of Shares. Subject to Section 3.4 of the Plan,
(a) upon (i) the repayment of the Associated Loan in accordance with Section D(11) or (ii) expiration of the applicable Restriction Period pursuant to Section D(12)(c) hereof (as applicable) and (b) prior to the occurrence of the
Agreement Termination Date, provided the Participant or his or her Permitted Transferee has executed the Management Stockholders’ Agreement, with respect to each Released Share, in the Board’s discretion, either (a) the
Participant’s or Permitted Transferee’s ownership of such shares shall remain recorded in a book-entry or similar system utilized by the Company or (b) certificates of shares of Common Stock shall be issued in the name of the
Participant or Permitted Transferee and delivered to such Participant or Permitted Transferee, in either case as soon as reasonably practicable following the Repayment Date or expiration of the Restriction Period (as applicable). Prior to the
Agreement Termination Date, no shares of Common Stock shall be issued to or recorded in the name of any Participant or Permitted Transferee until such Participant or Permitted Transferee agrees to be bound by and executes the Management
Stockholders’ Agreement. 
 (15) Company’ Rights Upon Participant’s Default. If the Participant
fails to pay all or any portion of the Repayment Amount for any Leveraged Share prior to the Forfeiture Date for such Leveraged Share, the Company or its designated assignee shall have (and shall automatically be deemed to exercise) the right,
pursuant to its Security Interest in such Leveraged Share, to reclaim from the Participant or his or her Permitted Transferee, and the Participant or such Permitted Transferee shall (and shall automatically be deemed to) transfer to the Company or
its designated assignee, as of such Forfeiture Date, such Leveraged Share (thereafter, a “Reclaimed Share”). The Participant’s transfer to the Company of any Reclaimed Share as described in the preceding sentence shall be in
full satisfaction of the Participant’s obligations with respect to the Associated Loan, and the Company shall have no further right to recover from the Participant or his or her Permitted Transferee, in cash or otherwise, any unpaid portion of
such Associated Loan. 
 (16) Amendment of Terms of Awards. The Board may, in its discretion, amend the
Plan, this Addendum or terms of any Award, provided, however, that any such amendment shall not impair or adversely affect a Participant’s rights under the Plan, this Addendum or such Award without such Participant’s written consent.

 (17) Adjustment Upon Changes in Company Stock; Rights as a Stockholder. Section 4.13 of the
Plan shall apply with respect to Awards granted pursuant to the Program in the same manner as it applies with respect to Options granted pursuant to Section 4 of the Plan. 

  
 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]